Use of Topiramate (Topamax) in a Subgroup of Migraine-Vertigo Patients with Auditory Symptoms

Annals of the New York Academy of Sciences

Volumn 1039, Issue , 2005, Pages 517-520

  Carmona, Sergio ^a   Settecase, Norma ^a  

^a Multiple Sclerosis Clinic Instituto Neurociencias Buenos Aires (INEBA)   (Argentina)

Author keywords

Migraine vertigo; Topamac; Topamax; Topiramate

Indexed keywords

CARBONATE DEHYDRATASE; TOPIRAMATE;

ADULT; AGED; AUDITORY SYSTEM; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HEARING LOSS; HUMAN; MALE; MIGRAINE; OPEN STUDY; PROPHYLAXIS; QUALITY OF LIFE; SIDE EFFECT; TINNITUS; TREATMENT OUTCOME; VERTIGO;

EID: 22144486546     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1325.057     Document Type: Conference Paper

References (7)

1. www.cdc.gov. 2004.
2. www.census.gov. 2004.
3. LEMPERT, T. & H. NEUHAUSER. 2004. Epidemiology and clinical aspects of migraine-associated dizziness [Abstr.]. J. Vestib. Res. 14: 84.
4. MATHEW, N. et al. 2003. Topiramate in migraine prevention (MIGR-001): effect on migraine sequency [Abstr.]. Neurology 60(Suppl. 1): A336.
5. BRANDES, J.L., J.R. SAPER, M. DIAMOND, et al. 2004. Topiramate for migraine prevention: a randomized controlled trial. JAMA 291: 965-973.
6. WELCH, K.M., G. D'ANDREA, N. TEPLEY, et al. 1990. The concept of migraine as a state of central neuronal hyperexcitability. Neurol. Clin. 8: 817-828.
7. NEUHAUSER, H. et al. 2001. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology 56: 436-441.